Join the PubAffairs Network

Established in January 2002, PubAffairs is the premier network and leading resource for the public affairs, government relations, policy and communications industry.

The PubAffairs network numbers over 4,000 members and is free to join. PubAffairs operates a general e-Newsletter, as well as a number of other specific group e-Newsletters which are also available to join by completing our registration form.

The PubAffairs e-Newsletters are used to keep members informed about upcoming PubAffairs events and networking opportunities, job vacancies, public affairs news, training courses, stakeholder events, publications, discount offers and other pieces of useful information related to the public affairs and communications industry.

Join the Network

Spent the week hibernating from the Arctic weather? Here's our roundup of what you might have missed in the world of health on Twitter last week.

  • @Jeremy_Hunt and @CMO_England set out new research on medication errors during a Facebook Live discussion
  • Theresa May met with Baroness Tessa Jowell to discuss proposals for the £45m investment in brain cancer research
  • FDA Commissioner sets out plan to bring down drug prices
  • @f4liverresearch were joined by Jeremy Hunt to unveil a statute to honour the career of Professor Williams
  • Monica Bulman, the UK’s longest serving nurse retired after 66 years at the age of 84
  • Parliament passed @Geoffrey4CovNW’s organ donation bill on Friday. @JulieElliottMP was one of many MPs who told personal stories in support of the Bill and how it will transform lives
  • The Royal College of Nursing highlighted that staff shortages are risking unsafe care for children
  • Some late chocolate valentines gifts were somewhat more lifelike than others…
  • Sir Andrew Cash, longtime NHS leader in Sheffield, announced that he would be retiring after four decades in the NHS
  • Could protein degraders be the future of medicines? The innovative new technique allows researchers to target all of the proteins made in the body, compared to 20% of current therapies
  • The 100,000 Genomes Project reaches the 50,000 genomes landmark

And finally:

Some nostalgia as David Cameron reminisces about his days at Chequers